Meghan Markle’s nephew has no problem profiting off her—or her child’s—namesake in his marijuana business.
For many aspiring cannabis growers, naming a strain after your aunt doesn’t easily translate to millions of dollars. Luckily, for aspiring cannabis grower Tyler Dooley, his aunt is none other than the Duchess of Sussex, Meghan Markle. Dooley, who calls himself the “black sheep” of the family, first made headlines when he created his first royals-related marijuana strain called Markle Sparkle.
The tagline for Markle Sparkle was pretty good, too: “So strong it will blow your crown off.”
But Dooley isn’t satisfied with just one royal family-related marijuana strain. He recently developed a new hybrid to honor his second cousin Archie, the blessed offspring of Markle and Prince Harry. He’s calling it “Archie Sparkie,” which he’ll grow on his 1,000-acre farm in Oregon.
“People have always called me the black sheep of the family but I’ve been working my ass off to make a living in a very competitive business,” Dooley told The Daily Mail. “Markle Sparkle made headlines and made me a lot of money.”
None of this, by the way, has been sanctioned by The Royal Family itself. Dooley, his father Tom, and grandpa Thomas Markle, Sr. were barred from the royal wedding, despite traveling overseas to attend. His farm’s success hasn’t won him any loyalty either, although Dooley is quick to mention his cannabis farm, Blue Line Hemp, brings in $200 million annually.
“The farm is organic and sustainable,” Dooley said. “It’s ironic my aunt and Prince Harry go on about being such great eco-warriors and yet they carry on jetting around on private planes. I think we’re doing more for the planet than my aunt Meghan is.”
CBD products tend to be expensive, even in small quantities. Here, we’ve compiled a list of a few brands and companies that make good CBD products for under $30.
CBD is one of the most popular ingredients out there. It’s used in lotions, sweets, dog treats, oils and more. It’s also expensive, with small containers of it having a price tag that ranges between $50 and $100 dollars.
Brian Baum, CEO of CANNOVIA, explained to Real Simplethat this phenomenon happens because of the limited supply of CBD and the growing demand for it. Although this will change in the coming two or three years, once CBD normalizes, for now, most products will stick with their price tags.
“On the supply side, the imbalance is due to the fact that hemp farming was generally illegal prior to the passage of the Farm Bill of 2018 (Agricultural Improvement Act of 2018), signed into law on December 20, 2018,” said Baum. “This first season is limited due to the lack of defined hemp farming guidelines issued by the USDA. Each state must then either implement the federal guidelines or develop their own plan for regulating hemp farming.”
We’ve compiled a list of well reviewed CBD products that can be purchased for under $30. These items include chocolates, bath salts, balms and more.
Developed by Made By Hemp, these chocolates contain 60mg of CBD per bar and come in easy to break pieces, with each block containing 15mg. It comes in four different flavors (raspberries & cinnamon, peanut butter & honey, caramel coconut drizzle and peach hazelnut) and you can purchase them online.
CBD bath salts and bombs are some of the least expensive CBD items on the market, with a lot of decent products being available for less than $30 dollars. Kush Queen has plenty of different bath bombs that come with different prices, ranging between 7 – 20 dollars. All of these feature delicious smells, creating a bath with tons of bubbles and cool colors. They also produce relaxing effects enhanced by CBD.
Shea Brand’s CBD Natural Pain Reliever is an all over body balm that provides a cooling sensation when applied, providing pain relief to any affected area. It contains arnica oil, black pepper, cinnamon, eucalyptus, ginger, peppermint and 50mg of CBD. You can purchase it online for $30.
There are many beloved CBD lip balms, some more expensive than others. For $13, Shea Brand sells a CBD restorative lip balm that contains anti-inflammatory properties, antioxidants, omega-3, omega-6 and different vitamins. It contains 25mg of CBD isolate. Vertly’s CBD lip balm is more expensive, costing $22, and comes in different flavors like cocoa, peppermint and rose scent.
Soaps
https://www.instagram.com/p/Bz1AWemjv_7/
Cannuka cleansing body bar is sold for $18, and it contains plenty of skin nourishing properties like CBD, Manuka honey and Black Pepper Essential Oil. According to the website, all of their soaps are hand cut and they work best with aging or acne prone skin, and people who suffer from psoriasis, dryness or dehydration.
Kanye West to Kim Kardashian: no more makeup for North!
The rapper and father of three has put a stop to his wife letting their 6-year-old daughter wear makeup, even if it’s just for play. While celebrating the launch of her KKW x WINNIE makeup collaboration in New York City this week, Kardashian told E! News about how her hubby reacted when he caught North wearing her mother’s lipstick.
“She loves makeup but her dad won’t let her wear it. I think he had it, he changed all the rules,” the beauty business woman said, explaining: “I’d let her wear, you know, she has a little red for Christmas, I’d let her wear a red lip, or I’d let her do one pop of something. I’d let her if she’s wearing a black dress, a black lip.”
Apparently things were fine until North’s aunt, Kylie Cosmetics founder Kylie Jenner, started gifting her niece “all these lip kits,” Kim said. “I kind of got in trouble for that. So, it’s now no more makeup.”
As documented on social media in the past, North has appeared wearing red lips for the Kardashian family’s annual Christmas Eve celebration. She’s also worn other lip colors for her dad’s Sunday services, like this dark lip she sported back in March.
Kim’s older sis, Kourtney Kardashian, also has a playful approach to allowing daughter Penelope, 6, play with makeup. “My daughter loves makeup,” Kourtney revealed while shooting her beauty routine for Vogue. “She has a little vanity in her room that my mom [Kris Jenner] gave her for Christmas. I let her play, and I try to keep her makeup as clean as possible.”
The Duke of Sussex turned 35-years-old on Sunday (September 15), and his wife, Meghan Markle, couldn’t wait to celebrate her sweetheart’s special day. Early yesterday morning, the Duchess took to the Sussex Royal Instagram page to spread some birthday cheer for the man she calls the “best husband” and “most amazing dad” with a touching picture collage and even sweeter message.
https://www.instagram.com/p/B2bDdAMlxgY
“Wishing a very happy birthday to His Royal Highness Prince Harry, The Duke of Sussex!” begins the caption for the celebratory post, which includes a special note from Markle that reads: “Your service to the causes you care so deeply for inspires me every day. You are the best husband and most amazing dad to our son. We love you Happiest birthday!”
Just a month before Harry’s anniversary, Markle celebrated her 37th birthday on August 4. Unlike last year’s trip to Botswana, the Duke took her to the wedding of family friend Charlie van Straubenzee.
It’s been quite an exciting year for the Royal couple, who welcomed their baby boy, Archie, back in May. Prince Harry and Duchess Meghan, who tied the knot in a royal wedding ceremony in May 2018, announced they were expecting their first child last October.
We’ve been doing our homework and have hand-picked five must-see cannabis-focused investor events that are business-focused, must-attend conferences for our finance buffs.
Cannabis and hemp-related events are proliferating as fast as CBD brands. A new event seems to pop up every week, adding to more than 500 listings a year in the U.S. alone.
Now, if you’ve ever attended more than one of these events, you’ve probably noticed most of them are very similar: the same topics, the same speakers, the same attendees, the same companies…It gets boring, unproductive, extremely time consuming, and expensive. In this context, every event organizer will claim their event is unique, like no other.
To make the situation worse for investors and people looking to network with other businesses and/or get their companies funded, investor-focused cannabis events, of which the U.S. witnesses more than 200 each year, boast higher-than-normal ticket prices, ranging from $50 to $2,000.
So, one cannot avoid but think twice before picking which ones to attend.
With so much noise, which ones are really worth the trouble — and travel?
Well, don’t worry. We’ve been doing our homework and have hand-picked five must-see cannabis-focused investor events that are business-focused, must-attend conferences for our finance buffs.
Photo by rawpixel.com
Kahner Global’s Cannabis Private Investment Summit Series
Kahner Global is a conference company and consulting firm founded in 2015 by Noa Kahner. It holds a number of conferences in New York, Beverly Hills, Fort Lauderdale, Toronto and San Francisco every year.
These conferences, part of Kahner’s Cannabis Private Investment Summit Series, are open to high-net-worth investors interested in the cannabis industry – of which there are many, as hedge funds and institutional investors are mostly staying away from the space, albeit slowly getting their feet wet.
Check out the next Kahner Global event September 17, in New York City. Speakers this year include
Anthony Scaramucci, Founder and Co-Managing Partner of SkyBridge Capital
JJ McKay, founder of The Fresh Toast
Famed NFL player and investor Tiki Barber
David Feldman, partner of Duane Morris LLP
Matt Hawkins, Managing Partner of Cresco Capital Partners
Jeanne M. Sullivan, General Partner at The Arcview Venture Fund
Lindy Snider, founder of Lindiskin
And many more
Photo by vjkombajn via Pixabay
Canex Jamaica
Canex Jamaica returns to Montego Bay, between September 26 and September 28.
The largest cannabis event in Jamaica manages to get the top movers and shakers in the industry together at a beautiful beach location for three full days of networking, panels, and parties. Speakers this year include:
Bruce Linton, founder of Canopy Growth Corp (NYSE: CGC)
Steve DeAngelo, famed activist and founder of Harborside Inc (OTC: HSDEF)
C.J. Wallace, founder of Think Big
Douglas K. Gordon, founder of CanEx
Emily Paxia, founding partner and managing director at Posiedon Investment Management
John Kagia, Chief Knowledge Officer at New Frontier Data
John Salley, entrepreneur, activist, and 5-time NBA champion
Robert Hoban, president and founder of Hoban Law
Javier Hasse, managing director of Benzinga Cannabis
Tahira Rehmatullah, president of T3 Ventures Advisory, partner of Big Tent Ventures and Ceylon Solutions, and member of the board of directors for Akerna Corp. (NASDAQ: KERN)
Vicente Fox, former President of Mexico
Photo by jirkaejc/Getty Images
IC3 (Institutional Capital & Cannabis Conference)
The Institutional Capital & Cannabis Conference (best known as IC3) is hosted by IMN, a global organizer of investment conferences that hosts over 50 events around the world each year.
The seventh edition of IC3 will take place October 21, in New York, and will see discussions about cannabis as an “exciting and high-growth new asset class, cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business.”
The Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference is one of the best events for cannabis entrepreneurs and investors in North America, hosted by financial media company Benzinga.
The fifth event in this series will be hosted in Chicago, Illinois, on October 22 and October 23. It will feature exclusive presentations by:
Scott Van Rixel, Chairman and CEO at Bhang Inc (OTC: BHNGF)
Jim Fickenscher and Will Roberts of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE)
Jessica Billingsley, CEO of Akerna Corp. (NASDAQ: KERN)
Tim Seymour, CIO at Seymour Asset Management
Kim Rivers, CEO of Trulieve Cannabis Corp (OTC: TCNNF)
Peter Miller, CEO and co-founder at SLANG Worldwide Inc (OTC: SLGWF)
Charles Bachtell, CEO and co-founder of Cresco Labs Inc (OTC: CRLBF)
Andy Williams, co-founder and CEO of Medicine Man Technologies Inc (OTC: MDCL)
And many more.
Photo by Darren415/Getty Images
Cowen & Company’s Boston Cannabis Summit
Cowen & Company is a well-known financial services firm with a rich history that covers over 100 years. It has become especially notable in the cannabis industry thanks to its very well known analyst, Vivien Azer, an eminence in the field.
Cowen hosts a series of events each year, covering various industries. This coming November 12 and November 13, cannabis will get its turn, as the firm hosts the 2nd Boston Cannabis Summit.
So, now that you know what our favorite cannabis investor conferences are, tell us: which are yours?
The UK rocker revealed that he has a family history of depression, and that cannabis has been a tool to help him get by.
Last year, The 1975 produced a strong argument that rock music is far from dead. Its look and texture has changed, but the Brit rock-pop group delivered the quintessential millennial anthem “Love It If We Made It” (Pitchfork named it the Best Song of 2018), not to mention hits like “It’s Not Living (If It’s Not With You” and “Sincerity Is Scary.” And according to a new feature from The FADER, marijuana might’ve played a significant role in the group’s musical creation.
The 1975’s Matt Healy, who went to rehab for heroin addiction, says cannabis has played a huge role in his recovery. In addition, the plants helps the singer stabilize his mental wellness, as he has a family history of depression. Healy himself has avoided getting diagnosed.
“Smoking weed has been a massive part of my life—it’s been, like, my tool, which sounds really bad,” Healy told The FADER. “But when I first started smoking weed, it was like this symphony in my head of every song I’ve ever written.”
“I could’ve gotten diagnosed when I was younger, but I knew they were just going to tell me to stop smoking weed,” he continued. “That wasn’t an option, so I never did. It’s as simple as that.”
While it’s easer to interpret that as someone who has developed a personal dependency, The 1975 frontman added that he can quit smoking anytime.
“I can’t [quit smoking marijuana] right at the moment, but I know I physically can,” he said. “When I have kids, I don’t want to be blazing up in front of my kids all the time.” Though he couldn’t help adding: “Surely I have some license to be a cool dad, right?”
This isn’t the first time Matt Healy opened up to a music publication about his marijuana usage. A couple years ago, Rolling Stone asked the UK rocker which was better: American or British weed?
“The kush in California is crazy. I always knew the weed was better in America, but I didn’t know how much better. The nugs are so big they look like cartoons.”
“Well, my generation wanna f*** Barack Obama / Living in a sauna with legal marijuana,” The 1975’s lead singer Matt Healy roars in their new single, “People.”
CBD today is marketed as a miracle cure-all, treating everything from headaches to cancer, as well as aid in mental wellness. But has the CBD market outpaced the known science?
CBD, or cannabidiol, is a non-psychoactive compound found in cannabis. It has seen a lot of interest recently, which has created a rush to establish a foothold in the rapidly-growing, emerging market. Accelerating this market boom is CBD’s purported medicinal properties, and since, for the most part, the compound, found in both cannabis and hemp, is marketed as a nutritional supplement, the ability to make health claims is encumbered only by a disclaimer that the FDA has not evaluated said promises. Unsurprisingly, CBD today is marketed as a miracle cure-all, treating everything from headaches to cancer, as well as aid in mental wellness. But has the CBD market outpaced the known science?
Two of the most popular ailments that proponents claim are sleep improvement and anxiety. One recent study, published in January of 2019, found promise in using CBD to treat anxiety-related disorders but concluded that controlled, clinical studies are needed, especially in light of so much interest within the lay population.
Pain management is another area in which CBD shows promise, with many current and retired athletes, individuals known for pushing their bodies for maximum performance, at the expense of lasting, chronic pain. Traditional pain and inflammation treatments, such as Ibuprofen, can cause long-term damage to internal organs, or in the case of more potent pain killers, like OxyContin, lead to addiction. Last year, the World Anti-Doping Agency removed CBD from its list of banned substances, perhaps a sign of CBD’s popularity and efficacy. But once again, research finds that while there is promise, no conclusive evidence exists because of a lack of consistent studies, also cautioning that longer-term trials are needed to understand the long-term effects and efficacy of CBD with regards to pain management.
The FDA has approved a pharmaceutical version of cannabidiol, sold under the name Epidiolex last summer, for the treatment of two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. Both syndromes begin to affect patients in childhood, with Dravet-related seizures appearing within the first year of life. CBD helps control seizures and improve quality of life. To date, the FDA has not approved use of CBD for any other conditions however.
Despite the science of how CBD works on our minds and bodies still being less than conclusive, at least by medical standards, that hasn’t stopped people from using and swearing by the curative properties of the cannabis-derived substance. And since the supplement is not as tightly regulated as medicine, those interested in using CBD should do their research into the manufacturer, and discuss it with their physician prior to use.
This week’s column highlights pop and indie music, with Ariana Grande, Miley Cyrus, Lana Del Rey, Grimes and Metronomy.
This Week’s Music is a weekly column that discusses the weeks’ best, worst, and most interesting songs. We try to select songs of different artists and genres to keep things interesting and to please a variety of music fans.
This week’s column features Ariana Grande, Miley Cyrus and Lana Del Rey’s super awaited collaboration, Metronomy’s “Wedding Bells,” and Grimes’ latest weird single.
Pop
Ariana Grande, Miley Cyrus and Lana Del Rey – Don’t Call Me Angel
Ariana, Miley and Lana have all had an incredibly successful year in terms of music and notoriety, releasing albums, having dramatic break ups and being some of the most revered celebrities in the world. If someone was going to release a song that follows Destiny’s Child’s “Independent Women,” it had to be something this big and dramatic. “Don’t Call Me Angel” is a strange song that leads to some fun results. While Ariana and Miley are a partnership that makes sense on the surface, Del Rey’s subdued presence adds a shimmer of mystique that fits the theme and song. It also helps that she’s just released one of the year’s most acclaimed records.
Grimes, as usual, is creepy as hell. Also, as usual, her rhythms are a blast, with a rich sound production that results in a trance-like anthem. Lyrically, “Violence” appears to be about an abusive relationship, but knowing Grimes it could be about politics, the weather or an ant. In a now deleted Instagram post she explained that each song on her upcoming album “will be a different embodiment of human extinction as depicted through a pop star Demonology.” Grimes is a weird one, but at least she’s interesting.
Metronomy – Wedding Bells
“Wedding Bells” is a part of Metronomy’s “Forever,” the British band’s most recent album. Six records in and Metronomy continues to cultivate their own type of sound, mixing rock, disco, and electronic music. With “Wedding Bells” they’ve achieved a wedding song that’s surprisingly playful and unromantic. Although it rapidly grows repetitive, it’s a fun addition into the band’s long and successful oeuvre.
Since the 17th century, these dogs have been bred to “point” at game birds in the wild. But the breed also makes for a great family pet.
With its muscular build, noble head and laser-focused expressions, the Pointer is described as a combination of athletic grace and power.
As the name suggests, the Pointer is meant to be in the field. Since the 17th century, these dogs have been bred to “point” at game birds in the wild. But the breed also makes for a great family pet in the right setting, such as a farm. It needs plenty of exercise, or will get frustrated and destructive.
Here, we find Pointers in their natural habitat, the field.
There is evidence that medical marijuana may not just help phobia patients manage anxiety, but may also help phobia suffers conquer their fears entirely.
This condition is classified as an irrational fear of something harmless that is perceived to be a threat. People with phobias often experience an immediate and sometimes overwhelming sense of panic when faced with, what they believe is, a dangerous place or situation. These severe anxiety attacks can come with rapid heartbeat, dry mouth, dizziness and even nausea. For many, this condition is quite debilitating. But there is evidence that medical marijuana may help phobia patients manage anxiety.
Recent studies have shown that two of the most common components of the cannabis plant may be effective in helping phobia patients.
In 2013, researchers from the University of Michigan published a paper in the journal Neuropsychology suggesting that THC has the power to treat phobias. What’s more is the study determined the cannabinoid may also help phobia suffers conquer their fears entirely.
To come to this conclusion, researchers exposed a group of subjects to the sources of their fears. They later conducted the experiment again after giving them synthetic THC. Over time, the test subjects showed no fear.
Last year, a study published by Frontiers in Pharmacology showed that CBD is also effective in the treatment of specific phobias. Researchers from the University of Birmingham said the non-intoxicating component of the cannabis plant has the ability to reduce fear memory.
“CBD both acutely inhibited fear expression and enhanced extinction to produce longer lasting reductions in fear,” the study reads. “These observations provide further support for the potential translational use of CBD in conditions such as … specific phobias.”
Although there are a number of prescription medications available for phobia patients, many complain that the side effects from these drugs are worse than the condition itself. However, considering the results of the latest research, it is conceivable that medical marijuana could potentially help millions of phobia sufferers live functional lives.
According to The Phobic’s Society, medical marijuana can be a good natural treatment for this severe anxiety disorder. “But it also has the potential to increase anxiety in larger dosages.” The organization encourages phobia suffers to try CBD strains rather than THC.
“Cannabidiol, or CBD, may be able to block additional anxiety caused by THC. While CBD does not produce the same feelings of high as THC, marijuana rich in the former may prove to be the better choice for anxiety relief.”
Cannabis has become one of the most effective and fast acting remedies for period cramps. We’ve compiled a list of some of the best products available.
Periods are the worst. Different women turn to all sorts of medications and practices for relief. Heating pads, exercise, pain meds, massages, yoga and herbal teas are some of the most recommended measures for pain relief, but for some, the pain is so acute that these methods are ineffective.
If you don’t know much about the cannabis industry, it may sound strange to read about marijuana tampons and suppositories. These products are designed to treat menstrual cramps effectively and won’t get you high.
Here are five of the best reviewed products out there.
These suppositories take around 15 minutes to work, and they directly affect your pelvis muscles and uterus, relaxing your insides and getting rid of all that tension. Each suppository contains around 60 mg of THC and 10 mg of CBD, and it’s best to use them right before bed or when you know you’re going to be laying down for a while. Relax, and let the suppositories do their thing.
A good remedy against pain and period cramps is relaxation, which can be facilitated with a nice long bath and some fancy bath salts. Whoopi & Maya’s bath salts (yes, made by that Whoopi) are effective and powerful, providing relief for up to 5 hours, and maybe leaving you a little loopy after your bath. Use with care; these salts contain around 25 mg of THC per 8oz container.
CBD Tinctures
Tinctures are very concentrated and strong, healing your pain with just a few drops if you can stomach the powerful and oily taste. They’re placed under your tongue, and they act fast, within 5 minutes your cramps will be gone and you’ll be feeling great. Tinctures are also a great and safe option for consuming during the daytime, because they won’t make you feel high at all.
This balm can be used anywhere on the body, including the vulva and vagina. Among other things, it’s an analgesic, so if your cramps are particularly powerful, add a spoonful of the balm to the insides of your vagina and let it melt. Love Your Lady Parts is effective, but messy, so be sure to sit still and wear your least favorite underwear.
This cream can be applied in your lower back and abdomen or any other area that’s been affected by your period. According to the product description, the cream releases tension in different areas and contains 4mg of CBD per 2ml dose.
Happiest birthday!”
